top of page
047d09_35a362ea29594511aef90a3efddd3213~mv2.jpg

DRIVE 3D TISSUE MODEL INNOVATION BACKED BY SCIENTIFIC COMPLIANCE

We help life-science innovators turn New Approach Methodologies (NAMs) and advanced models into credible, adoption-ready solutions.

About MAG-AN

MAG-AN is an international scientific consultancy enabling the transition to non-animal, human-relevant biomedical research. Founded by Benjamin Anbiah, CSci, we operate at the intersection of scientific innovation, validation, and regulatory alignment.

 

We support biotech companies, research organisations, and translational programmes in adopting microphysiological systems (MPS), advanced 3D tissue models, and non-animal testing strategies through a compliance-first approach. Our work focuses on delivering reproducible, regulator-ready, and globally aligned R&D outcomes across the UK, US, and India.

 

In parallel, MAG-AN is developing internal digital tools and AI-assisted workflows to support compliance mapping, study documentation, and regulatory alignment for non-animal research. These tools are being shaped through real-world consulting engagements and reflect our longer-term ambition to scale validated scientific and compliance expertise through digital platforms.

ABOUT MAG-AN

MAG-AN is an international scientific consultancy founded by Benjamin Anbiah (CSci). We specialize in non-animal testing strategies, micro-physiological systems (MPS), regulatory alignment, and advanced biomedical R&D.

Our work bridges innovation with compliance-first execution — ensuring research teams achieve reproducible, human-relevant, and globally aligned outcomes.

image.png

WHAT WE OFFER

New Approach Methodology Strategy

  • Model selection (3D tissue and MPS)

  • Validation frameworks

  • NAM Transition planning.

Regulatory and Quality Alignment

  • ISO/OECD-compliant documentation

  • Regulatory readiness frameworks

  • audit-aligned systems

  • NAM's compliance mapping

Lab Setup and Scientific Operation

  • Assay development and workflow refinement

  • Infrastructure and lab planning

  • Operational Optimisation.

  • Reproducibiity and Scaleup Support

Funding and Translational Support

  • Grant and proposal stratergy

  • Scientific review and positioning

  • Translation pathway planning

  • Industry and regulatory allignment

MAG-AN enables the transition from spin-out innovation to real-world adoption by addressing validation, operational, and regulatory gaps in line with the FDA Modernization Act 2.0.

We support organisations by:

  • Defining and refining Context of Use (CoU) to ensure appropriate and defensible application of advanced models

  • Identifying and closing validation and reproducibility gaps aligned to the intended CoU

  • Designing benchmarking and performance criteria relevant to regulatory decision-making

  • Translating spin-out and academic workflows into operationally scalable programmes

  • Mapping studies and evidence to FDA, OECD, and NAMs regulatory pathways

  • Leveraging AI-assisted internal tools to support compliance mapping, documentation, and consistency across NAMs-based workflows

BG.png

Stay Connected !

 

Let’s Start the ConversationHave questions or interested in collaborating? MAG-AN Scientific & Technical Consultancy supports organisations navigating the transition to NAMs-based, human-relevant, and regulator-ready biomedical research. We work with research teams, spin-outs, and biotech companies to align innovation with real-world application and regulatory expectations.Our team is ready to support you with strategic, scientific, and compliance-focused guidance across the UK, US, and India.

Benjamin Anbiah

CSci, MInstST

Founder & Scientific Consultant

07776614713

Institute of Cancer Research,

The Innovation Geteway,

Cotswold Rd,

Sutton SM2 5NG

Connect with Us

 

© 2035 by MAG-AN Scientific Consultancy Ltd. Powered and secured by Wix 

 

bottom of page